Does MITOMYCIN Cause Malignant neoplasm progression? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Malignant neoplasm progression have been filed in association with MITOMYCIN (MUTAMYCIN). This represents 1.2% of all adverse event reports for MITOMYCIN.
26
Reports of Malignant neoplasm progression with MITOMYCIN
1.2%
of all MITOMYCIN reports
7
Deaths
3
Hospitalizations
How Dangerous Is Malignant neoplasm progression From MITOMYCIN?
Of the 26 reports, 7 (26.9%) resulted in death, 3 (11.5%) required hospitalization, and 2 (7.7%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MITOMYCIN. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does MITOMYCIN Cause?
Off label use (292)
Drug ineffective (117)
Diarrhoea (116)
Nausea (100)
Neutropenia (96)
Thrombocytopenia (94)
Fatigue (88)
Disease progression (86)
Rash (67)
Vomiting (66)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which MITOMYCIN Alternatives Have Lower Malignant neoplasm progression Risk?
MITOMYCIN vs MITOTANE
MITOMYCIN vs MITOXANTRONE
MITOMYCIN vs MITRAGYNINE\HERBALS
MITOMYCIN vs MIZORIBINE
MITOMYCIN vs MOBOCERTINIB